For example mitoxantrone, an anthracycline analogue, can result in cardiotoxicity that is not clinically different from the cardiac damage caused by true anthracyclines. Druginduced mitochondrial dysfunction and cardiotoxicity. Cardiotoxicity is not restricted to anticancer agents, and almost. Cardiotoxicity of noncardiovascular drugs is an essential guide to this important area of drug development. Aug 21, 2012 many children and adolescents with cancer receive chemotherapeutic agents that are cardiotoxic. The need for cardiooncology and cardiooncological prevention adriana albini, giuseppina pennesi, francesco donatelli. Early detection of the patients proneness for developing cardiotoxicity is the key issue to decrease morbidity and mortality. Radiotherapy delivers energy via ionising radiation to neoplastic cell dna in such a way that the resultant damage. The incidence and severity of cardiovascular side effects are dependent on the type of drugs used, dose and schedule employed, and age of patients, as well as the presence of coexisting cardiac diseases and previous mediastinal irradition. This book intends to bring forward the recent development in toxicities from cancer treatment. Cardiotoxicity of cancer chemotherapy springerlink. Anticancer treatments and cardiotoxicity sciencedirect.
The attack is generally directed against metabolic sites essential to cell replicationfor example, the availability of purines and pyrimidines that are the building blocks for dna or rna synthesis ideally, anticancer drugs should interfere only. Anticancer drug s are agents that demonstrate activity against malignant disease. The extent of cardiotoxicity is variable, depending on the type of drug used, combination with other drugs, prior mediastinal radiotherapy and the presence of cardiovascular risk factors or history of heart disease. The mechanism of cardiotoxicity studied in vitro and in vivo essentially concerns the formation of free radicals leading to oxidative stress, with apoptosis of cardiac. Apr 01, 2008 many antitumor drugs cause on treatment cardiotoxicity or introduce a measurable risk of delayed cardiovascular events. Much research needs to be done to identify the most appropriate protective strategies against the development of ctrcd in cancer patients. Cardiotoxicity is a condition when there is damage to the heart muscle. Nowadays improvement in overall survival in patients suffered from cancer is observed. A significant milestone in the treatment of breast cancer is the identification of the her2 receptor as a drug target for cancer therapies.
Jan 14, 2014 anticancer drugs 1 introduction and classification 1. Trastuzumab herceptin, a monoclonal antibody that blocks the her2 receptor, is among the first of such drugs approved by the us food and drug administration for targeted cancer therapy. Druginduced cardiotoxicity of breast cancer treatment. Risk factors for cardiotoxicity induced by anthracyclines. Heart failure cancer cardiotoxic drugs cfr journal. This section on pharmacology of anti cancer drugs is devoted to the publication of high quality research concerning all aspects of cancer and benign neoplasm drug treatment.
This may be due to chemotherapy drugs, or other medications you may be taking to control your disease. A decrease in vascular endothelial growth factor vegf results in a reduction of nitric. Cardiotoxicity from drug developmental perspective. This article explores the relationship of these treatments to cardiotoxicity, the indicative signs and symptoms and the management options available. As a result of cardiotoxicity, your heart may not be able to pump blood throughout your body as well. Be sure to verify your new user account in the next 24 hours, by checking your email and clicking the verify link. However, cancer treatmentrelated cardiotoxicity is the leading cause of treatmentassociated mortality in survivors of pediatric and adolescent cancers. It describes cytotoxic drugs used in chemotherapy, new anticancer. Cancer treatmentrelated cardiotoxicity egrpdccpsncinih. Anticancer drugs 1 introduction and classification 1. Frontiers in pharmacology pharmacology of anticancer drugs.
Anti cancer drugs are also called anti neoplastic agents or chemotherapeutic agents. In an effort to classify cardiotoxicity of cancer drugs, ewer et al. Cardiotoxicity and cardiomyopathy managing side effects. Classically, anthracyclines are among one of the most active agents in. Cardiotoxicity of anticancer treatments is associated with development of. This article has been saved into your user account, in the favorites area, under the new folder. Mechanisms, diagnostic and therapeutic interventions presents cutting edge research on the adverse cardiac effects of both radiotherapy and chemotherapy, brought together by leaders in the field. Cancer treatmentrelated cardiotoxicity is the leading cause of treatmentassociated mortality in cancer survivors and is one of the most common posttreatment issues among survivors of adult cancer. They include alkylating agents, antimetabolites, one of the first drugs that was used clinically in modern medicine for the treatment of cancer was the alkylating agent mechlorethamine, a nitrogen mustard that in the 1940s was found to be effective in treating. Kelleni and others published drug induced cardiotoxicity.
Cardiotoxicity may be caused by radiotherapy andor anticancer agents for many malignancies, adverse effects of some drugs in the context of medical intervention or heavy metal intake, especially during the anticancer therapy. The often observed side effect of anti cancer therapy is cardiotoxicity. Partly due to improvements in treatment, the population of cancer survivors is large and growing. From 1935 to 2010, heart disease and cancer were the first and second most common causes of death in the united states. Any cancer drug that may lead to myocyte injury or destruction can induce irreversible cardiotoxicity. Progress in the detection and treatment of cancer has led to an impressive reduction in both mortality and morbidity. Although rare, cardiotoxicity is a significant complication of cancer treatment. How to improve therapeutic strategies to reduce cardiotoxicity. Longterm mortality from heart disease and lung cancer after radiotherapy for early breast cancer. They can be used alone singledrug therapy or several at once combination therapy. Cardiotoxicity of antitumor drugs chemical research in. The decision about further treatment in cancer patients can be affected by the risk of development of this complication.
Mechanism, prevention and management find, read and. During chemotherapy, you are given toxins drugs to kill cancer cells. This chapter presents examples of proven cardiac toxicity associated with oncology treatment. Cardiovascular events may occur also with other chemotherapeutics, but the dose or metabolism. Thus, while survival rates in this population have improved for some cancers, many survivors may experience acute or chronic cardiovascular complications that can impair their quality of life years after treatment. Anticancer treatments and cardiotoxicity 1st edition elsevier. Due to their mechanism of action, however, conventional chemotherapeutics and some of the newer anti cancer signaling inhibitors carry a substantial risk of cardiovascular side effects that include cardiac dysfunction and heart failure, arterial hypertension. Anticancer treatments and cardiotoxicity 1st edition. Lopez sendon, in anticancer treatments and cardiotoxicity, 2017. A sideeffect is that the normal cells in and around your heart can also be killed. Some studies also suggest that anticancer drugs, such as anthracycline. Pharmacology notes ppt pdf anticancer drugs what is. Antiher2 cancer therapy and cardiotoxicity bentham science.
Cancer treatmentrelated cardiotoxicity is the leading cause of treatmentassociated mortality in cancer. Several publications 24,712 have focused on the cardiotoxicity of specific classes of cancer therapeutic agents and recently, we have begun to see a global analysis of the diverse classes together. Cardiovascular diseases and cancer represent respectively the first and second cause of death in industrialized countries. Cardiotoxicity accounted for 45% of all drugs withdrawn between 1994 and 2006, which was due mainly to cardiac ischemiarelated and arrhythmogenic side effects. Sep 15, 2017 mabs, the main cause of type 2 damage, are widely used in the management of many types of cancer. C ardiovascular diseases and cancer remain major causes of mortality and morbidity in the united states and across europe. Early detection of the patients prone to developing cardiotoxicity, taking in to account the type of treatment, history and other risk factors, is essential in the fight to decrease cardiotoxic mortality. It will find a place on the bookshelves of researchers, regulators and students in medicinal chemistry, drug. The goals of anti cancer therapies are to prevent recurrence, prolong life, and provide cure. They act upon rapidly dividing cancer cells and destroy them. It is these two anti cancer therapies that are implicated in the emerging field of cardiooncology, whether the aim of cancer treatment is curative or palliative table 1. Insights and perspectives in the era of targeted therapy druginduced cardiotoxicity is emerging as an important issue among cancer survivors. Doxorubicin and other anthracyclines cause congestive heart failure that develops in a dosedependent manner and reflects the formation of toxic drug metabolites in the heart. Effects of anticancer therapy on the cardiovascular system.
Scribd is the worlds largest social reading and publishing site. Request pdf anti her2 cancer therapy and cardiotoxicity a significant milestone in the treatment of breast cancer is the identification of the her2 receptor as a drug target for cancer. Chemotherapy agents that can cause reversible cardiotoxicity are trastuzumab, bevacizumab, lapatinib, and sunitinib. Hypertension is the most frequent cardiotoxicity observed with vsp inhibitors, with a reported incidence of 19% to 47% see table 3. In addition, cardiac complications of treatment lead to reductions in dose and. Animal models in studies of cardiotoxicity side effects from. Anticancer drugsinduced cardiotoxicity, heart failure, anthracyclines, her2, vegf, immunotherapy. Anticancer drugs the anticancer drug either kill cancer cells or modify their growth. However, some clinical trials have cast doubt on whether the cardiotoxic effects of these drugs are in fact reversible, and combined anticancer therapy with class. Purchase anticancer treatments and cardiotoxicity 1st edition. Professional books consumer books acs professional resources acs research grants. It is crucial that cardiotoxicity in cancer patients be managed effectively by the healthcare practitioner in order to decrease the mortality and morbidity associated with the underlying malignancy. Antiher2 cancer therapy and cardiotoxicity request pdf. Cancer treatmentrelated cardiotoxicity includes efforts to identify individual toxicity risks and prevention strategies support the national cancer insitutes goal of reducing the burden of cancer diagnoses and treatment outcomes.
Cardiotoxicity related to anticancer drug treatment. Cardiotoxicity is not restricted to anticancer agents, and almost all therapeutic drug classes have unanticipated cardiotoxicities. The most common pathophysiological mechanism of anthracyclineinduced cardiotoxicity is the oxidative stress hypothesis, which suggests that the generation of reactive oxygen species and lipid peroxidation of the cell membrane damage cardiomyocytes. The scope of the specialty section encompasses studies related to drugs targeting tumor cells, but also the various components of the tumor microenvironment, including nontumor cells e. Cardiotoxicity is an important side effect of cytotoxic drugs and may be a risk factor of longterm morbidity for both patients during therapy and also for staff exposed during the phases of manipulation of antiblastic drugs. Cardiotoxicity, cancer treatment, anthracycline, tyrosine kinase inhibitors, cardiovascular diseases, stem cells, cardiac progenitors, regenerative medicine. Cardiac complications of cancer treatment intechopen. Cancer and heart disease are the leading causes of morbidity and mortality in the industrialized world. The advent of these various targeted therapies, however, has increased the incidence of cardiotoxicity related events in cancer patients.
755 453 1067 383 885 1322 863 445 1022 346 1013 220 130 1398 747 1417 585 540 1248 814 443 281 658 1202 481 862 1049 1361 803 413 1443 29